⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNCX News
Quince Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
QNCX
Form 8-K/A
sec.gov
QNCX
UPDATE - Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
globenewswire.com
QNCX
Form 8-K
sec.gov
QNCX
Quince Announces Acquisition of Orphai and up to $187 Million Private Placement to Advance Pulmonary Pipeline
globenewswire.com
QNCX
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
globenewswire.com
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX